Jay Chatfield, Mph, Pm-Lpc
AeroLeads people directory · profile

Jay Chatfield, Mph, Pm-Lpc Email & Phone Number

Medical Affairs Strategy and Medical Affairs Director - Oncology, Hematology, Immunology Rare Disease at Cogent Biosciences
Location: Greater Philadelphia, United States, United States 11 work roles 2 schools
1 work email found @cogentbio.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email j****@cogentbio.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Medical Affairs Strategy and Medical Affairs Director - Oncology, Hematology, Immunology Rare Disease
Location
Greater Philadelphia, United States, United States
Company size

Who is Jay Chatfield, Mph, Pm-Lpc? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Jay Chatfield, Mph, Pm-Lpc is listed as Medical Affairs Strategy and Medical Affairs Director - Oncology, Hematology, Immunology Rare Disease at Cogent Biosciences, a company with 234 employees, based in Greater Philadelphia, United States, United States. AeroLeads shows a work email signal at cogentbio.com and a matched LinkedIn profile for Jay Chatfield, Mph, Pm-Lpc.

Jay Chatfield, Mph, Pm-Lpc previously worked as Sr. Medical Science Liaison & Medical Insights, Oncology/Hematology/Immunology Rare Dx at Cogent Biosciences and Senior Cardiovascular - Immunology Medical Science Liaison, Rare Disease at Kiniksa Pharmaceuticals. Jay Chatfield, Mph, Pm-Lpc holds Master Of Public Health - Mph, Public Health & Health Policy from University Of Liverpool.

Company email context

Email format at Cogent Biosciences

This section adds company-level context without repeating Jay Chatfield, Mph, Pm-Lpc's masked contact details.

*@cogentbio.com
71% confidence

AeroLeads found 1 current-domain work email signal for Jay Chatfield, Mph, Pm-Lpc. Compare company email patterns before reaching out.

Profile bio

About Jay Chatfield, Mph, Pm-Lpc

*PROFESSIONAL SUMMARY*Rare disease KOL Scientific Strategist with Market Access and HEOR strengths influencing KOL Advocacy and Value Communication channels. Possesses significant experience in KOL engagement, project management, outcomes research data enrichment, and disease program development amongst diverse customer segments. Substantial knowledge concerning the development of scientific materials to promote dialogue among professional societies, commercial payers, and academic medical centers. A respected reputation and value analysis approach has resulted in the translation of accountable care issues into big picture patient-centered benefits. Thrives on cultivating peer-to-peer relationships and strategic alliances that help KOLs succeed in implementing clinical initiatives, with the fundamental goal of improving patient care. Therapeutic background: Allergy, Immunology, Oncology, Obesity, CNS/Neuro, Infectious Disease, Cardiovascular, Metabolic/Diabetes.

Listed skills include Pharmaceutical Industry, Diabetes, Cross Functional Team Leadership, Strategy, and 26 others.

Current workplace

Jay Chatfield, Mph, Pm-Lpc's current company

Company context helps verify the profile and gives searchers a useful next step.

Cogent Biosciences
Cogent Biosciences
Medical Affairs Strategy and Medical Affairs Director - Oncology, Hematology, Immunology Rare Disease
Philadelphia, PA, US
Website
Employees
234
AeroLeads page
11 roles

Jay Chatfield, Mph, Pm-Lpc work experience

A career timeline built from the work history available for this profile.

Medical Affairs Strategy And Medical Affairs Director - Oncology, Hematology, Immunology Rare Disease

Philadelphia, PA, US

Sr. Medical Science Liaison & Medical Insights, Oncology/Hematology/Immunology Rare Dx

Current

Waltham, Massachusetts, US

Mar 2023 - Present

Senior Cardiovascular - Immunology Medical Science Liaison, Rare Disease

Lexington, Massachusetts, US

*Launched rilonacept (1st in class biological therapy) for recurrent pericarditis with primary role in educating KOLs/Payers on mechanism of disease and science relative to IL-1 alpha and IL-1 beta*Organized and advanced rilonacept therapeutic awareness and recurrent pericarditis data at advisory boards and round table discussions with KOLs*Led and.

Jan 2019 - Mar 2023

Mph Student

Liverpool, Merseyside, GB

*Conducting dissertation research to investigate the influence of peer support groups/digital patient engagement on health literacy, self-efficacy, and medication adherence among Medicare beneficiaries*-Designed study protocol, developed informed consent process, gained local ethics approval, and built longitudinal patient engagement surveys via.

Sep 2016 - Jun 2020

Managing Consultant, Clinical Operations/Clinical Development

London, England, GB

*Four-month contract/project**Tailored business process solutions to support J&J Global Clinical Operations in delivering change management and market strategy programs*Leveraged J&J transformation methodologies to identify patient treatment paths, therapeutic area segments, and the value of seeking new indications*Provided portfolio management.

Dec 2017 - Mar 2018

Sr. Manager/Associate Director, Professional Relations, Market Access & Strategic Alliances

La Jolla, CA, US

*Executed stage-gate system as a roadmap to drive performance-based/value-based contracting strategies to the marketplace*Developed value proposition budget-impact calculations to determine significance of obesity therapy from the viewpoint of those influencing the determination to grant access *Directed market access strategy for self-insured employers.

May 2016 - Sep 2017

Associate Director, U.S. Marketing, Hospital-Antibiotics, Kol/Payer Scientific Strategy

Rahway, New Jersey, US

*Generated scientific awareness and led KOL - HEOR engagement tactical development and (KPI) monitoring activities *Administered decision modeling exercises and focus groups with professional societies and patient advocacy organizations to optimize market entry at launch*Led payer segmentation and reimbursement projects to further understand and optimize.

Oct 2015 - May 2016

Associate Director, U.S. Strategic Alliances & Business Development, Portfolio/Project Manager

Rahway, New Jersey, US

*Cultivated relationships with Key Customers (i.e., IDNs, Johns Hopkins, and CECity - Premier, Inc.) by identifying opportunities to develop population health management platforms utilizing predictive analytics, care pathway algorithms, and eHealth-decision support tools *Operationalized strategy for multi-phase Vaccine Population Health Commercialization.

Mar 2014 - May 2016

Cardiovascular-Metabolic Medical Science Liaison

Rahway, New Jersey, US

*Launched 1st in class DPP-IVi, with principal role in educating KOLs/Payers on mechanism of action and science relative to GLP-1 axis*Advanced scientific materials to promote scientific dialogue among commercial payers and health system pharmacy - therapeutics committees*Developed U.S. diabetes and obesity portfolio strategy for payers/academic medical.

Aug 2005 - Mar 2014

Cardiovascular-Metabolic Specialist

Rahway, New Jersey, US

Jul 2003 - Aug 2005

Cardiovascular-Metabolic Professional Representative

Rahway, New Jersey, US

Jan 2001 - Jul 2003
Team & coworkers

Colleagues at Cogent Biosciences

Other employees you can reach at cogentbio.com. View company contacts for 234 employees →

2 education records

Jay Chatfield, Mph, Pm-Lpc education

Master Of Public Health - Mph, Public Health & Health Policy

University Of Liverpool

Bachelor Of Arts, Marketing, Communications, Sociology

Stephen F. Austin State University
FAQ

Frequently asked questions about Jay Chatfield, Mph, Pm-Lpc

Quick answers generated from the profile data available on this page.

What company does Jay Chatfield, Mph, Pm-Lpc work for?

Jay Chatfield, Mph, Pm-Lpc works for Cogent Biosciences.

What is Jay Chatfield, Mph, Pm-Lpc's role at Cogent Biosciences?

Jay Chatfield, Mph, Pm-Lpc is listed as Medical Affairs Strategy and Medical Affairs Director - Oncology, Hematology, Immunology Rare Disease at Cogent Biosciences.

What is Jay Chatfield, Mph, Pm-Lpc's email address?

AeroLeads has found 1 work email signal at @cogentbio.com for Jay Chatfield, Mph, Pm-Lpc at Cogent Biosciences.

Where is Jay Chatfield, Mph, Pm-Lpc based?

Jay Chatfield, Mph, Pm-Lpc is based in Greater Philadelphia, United States, United States while working with Cogent Biosciences.

What companies has Jay Chatfield, Mph, Pm-Lpc worked for?

Jay Chatfield, Mph, Pm-Lpc has worked for Cogent Biosciences, Kiniksa Pharmaceuticals, University Of Liverpool, Chaucer Consulting, and Orexigen Therapeutics.

Who are Jay Chatfield, Mph, Pm-Lpc's colleagues at Cogent Biosciences?

Jay Chatfield, Mph, Pm-Lpc's colleagues at Cogent Biosciences include Elissa Rivers-Schappe, Lisa Huseas, Alex Manning, Paul Russell Carlson, and Jing Y..

How can I contact Jay Chatfield, Mph, Pm-Lpc?

You can use AeroLeads to view verified contact signals for Jay Chatfield, Mph, Pm-Lpc at Cogent Biosciences, including work email, phone, and LinkedIn data when available.

What schools did Jay Chatfield, Mph, Pm-Lpc attend?

Jay Chatfield, Mph, Pm-Lpc holds Master Of Public Health - Mph, Public Health & Health Policy from University Of Liverpool.

What skills is Jay Chatfield, Mph, Pm-Lpc known for?

Jay Chatfield, Mph, Pm-Lpc is listed with skills including Pharmaceutical Industry, Diabetes, Cross Functional Team Leadership, Strategy, Medical Affairs, Therapeutic Areas, Product Launch, and Life Sciences.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.